Ep. 14 - Investor Sentiment, HCQ Redux and Attacking AMR
Reach us by sending a text
BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs.
For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.